← Back to Search

Social Network Coaching for Cancer (SONATA Trial)

N/A
Recruiting
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks
Awards & highlights

SONATA Trial Summary

This trial will study if a 4-month, 6-session coaching program helps older cancer patients. The sessions will last 1-2 hours, and happen every 1-2 weeks.

Who is the study for?
This trial is for individuals aged 65 or older who have been diagnosed with cancer and are starting or within the first three months of oral cancer treatments. They must be able to consent, speak English, and identify at least one person from their social network to join them in the program.Check my eligibility
What is being tested?
The SONATA program is being tested to see if it helps older adults with cancer by providing social support through coaching sessions. Participants will engage in six sessions over approximately four months aimed at enhancing trust and adherence to treatment.See study design
What are the potential side effects?
Since SONATA is a social support intervention rather than a medication, there may not be physical side effects like those associated with drugs. However, participants might experience emotional discomfort discussing personal issues during sessions.

SONATA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability- SONATA Intervention
Feasibility - SONATA Intervention
Secondary outcome measures
Estimate - Adherence to oral anticancer treatments
Estimate - Social Support
Estimate - Trust in Healthcare Professionals

Side effects data

From 2011 Phase 2 trial • 67 Patients • NCT00878553
3%
Headache
1%
Infusion Site Pain
1%
Dizziness
1%
Sinus Headache
1%
Diarrhoea
1%
Nasopharyngitis
100%
80%
60%
40%
20%
0%
Study treatment Arm
20mg
Placebo
10 mg
15mg

SONATA Trial Design

1Treatment groups
Experimental Treatment
Group I: Arm 1 - SONATA InterventionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
840 Previous Clinical Trials
534,554 Total Patients Enrolled

Media Library

SONATA Clinical Trial Eligibility Overview. Trial Name: NCT05745038 — N/A
Cancer Research Study Groups: Arm 1 - SONATA Intervention
Cancer Clinical Trial 2023: SONATA Highlights & Side Effects. Trial Name: NCT05745038 — N/A
SONATA 2023 Treatment Timeline for Medical Study. Trial Name: NCT05745038 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment seeking additional participants?

"This study, which was first introduced on April 1st 2023 and lastly updated nearly two months later, is not currently looking for volunteers. Nevertheless, there are 505 other trials actively recruiting participants as of now."

Answered by AI
~25 spots leftby Dec 2024